Market Tracker

10/21 11:10am ET

Northwest Biotherapeutics Inc (NASDAQ:NWBO)

5.08
Real-Time Quote
 +0.24 / +4.96%
Today’s Change
3.10
Today|||52-Week Range
10.64
+34.75%
Year-to-Date

Today’s Trading

Previous close4.84
Today’s open4.86
Day’s range4.83 - 5.07
Volume132,611
Average volume (3 months)486,241
Market cap$299.0M
Dividend yield--
Data as of 10:55am ET, 10/21/2014

Growth & Valuation

Earnings growth (last year)+65.03%
Earnings growth (this year)+8.50%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+4.79%
P/E ratioNM
Price/Sales153.15
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AMBIAmbit Biosciences Co...-0.03-0.19%
RGLSRegulus Therapeutics...-0.01-0.15%
AGTCApplied Genetic Tech...+0.05+0.27%
TKAITokai Pharmaceutical...+0.13+1.00%
Data as of 10:55am ET, 10/21/2014

Financials

Next reporting dateNovember 14, 2014
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$809.0K
Annual profit (last year)-$65.8M
Net profit margin-8,132.14%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO, CFO &
CAO
Linda F. Powers
Chief Scientific Officer, Secretary &
Director
Alton L. Boynton
Corporate headquarters
Bethesda, Maryland

Forecasts